http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Sunbrella® and CW Stockwell Debut New Fabrics at Legends of DesignLA
-
JIM BEAM® LAUNCHES "RAISED TOGETHER" GLOBAL BRAND FILM AHEAD OF FORMULA 1® SEASON OPENER
-
Norsemont Targets Filing Environmental Impact Declaration in December 2026
-
Angkor Resources Announces Stock Option Grant
-
Ainos secures initial order for 1,400 AI Nose systems worth $2.1 million
-
HYCU® Recognized As A 5 Star Program In The 2026 CRN® Partner Program Guide
-
American Resources Corporation and ReElement Technologies Announce Attendance at the PDAC Conference in Toronto
-
Ainos Issues Shareholder Letter on Phased AI Nose Deployment of Up to 20,000 Systems and Scalable Recurring Revenue Opportunity
-
OZOP Energy Solutions, Inc. Announces Addition of Seasoned Beverage Industry Executive Ty Gilmore to Varon Commercial Leadership
-
RESEARCH FRONTIERS TO HOST FOURTH QUARTER AND YEAR-END2025 CONFERENCE CALL
-
Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
-
Institutional Confidence in Golden Matrix Group (GMGI) Strengthens in Q4 2025
-
OneSpan completes acquisition of mobile security firm Build38
-
Victory Capital appoints Molly Weiss as chief technology officer
-
Molly Weiss Named Chief Technology Officer and Head of Digital Innovation
-
Collective Metals Announces Plans for Inaugural Drill Program at the Rocas Uranium Project
-
Subway® Canada Launches New All Dressed Sauce Inspired by Ruffles®, Bringing an Iconic Canadian Flavour to Subs Nationwide
-
OneSpan Completes Acquisition of Build38
-
EraNova Metals Reports Samples of up to 257 g/t Gold and 3,660 g/t Silver at Lakeview and Defines New Drill Target on the Ruby Creek Property
-
Trevi Therapeutics to Participate in Upcoming March Conferences
-
Twenty Years After Walmart Opens at Marina Landing, What's Next?
-
NovoCure receives Japan reimbursement approval for lung cancer device
-
Spring Officially Starts at Rita's® with Free Italian Ice Giveaway and New Mystery PEEPS® Flavor
-
TAE Technologies Announces Cedric Burgher as Chief Financial Officer
-
Green Rain Energy Holdings Inc. (OTC: GREH) Announces March 31, 2026 Record Date for Special Stock Dividend
-
Novocure Announces Optune Lua® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
-
EPR Cable Market worth $5.96 billion by 2032 - Exclusive Report by MarketsandMarkets™
-
EchoStar Announces Financial Results for the Three and Twelve Months Ended December 31, 2025
-
Palo Alto Networks announces partnerships for AI infrastructure security
-
HTX Opens Trading for BTW (Bitway)
-
New Initiative Readies Wholesale Access for the Full Fiber and Cloud Era
-
Arrcus and UfiSpace Collaborate on AI-Optimized Networking Platforms with Enhanced Scale and Security from the Edge to Core
-
Vantiva Unveils New Hawk 5G FWA Home Gateway, designed for 5G SA
-
Palo Alto Networks and Global Partners Announce Secure by Design AI Factories
-
Bitget Lists Fabric Protocol (ROBO) for Spot Trading
-
Bitget Publishes February 2026 Proof of Reserves, Maintaining 169% Total Reserve Ratio
-
Bitget and Obside Partner to Launch Live AI Trading Arena for Copy Trading
-
WELIREG(R) (belzutifan) Plus LENVIMA(R) (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Ca
-
Golden Cariboo Resources Intends to Commission Independent NI 43-101 Mineral Resource Estimate for Halo and Main Zones
-
How to Trade Meme Coins in Q1 March: Is APEMARS the Next Meme Coin After Shiba Inu and SPX6900?
-
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
-
New Stamps Feature Quilt Masterpieces From Harriet Powers
-
KEYTRUDA Plus WELIREG Shows 28% Reduction in Cancer Recurrence Risk
-
KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Given as Adjuvant Therapy Reduced the Risk of Disease Recurrence or Death by 28% Compared to KEYTRUDA Monotherapy in Certain Patients With Earlie
-
WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Reduced the Risk of Disease Progression or Death by 30% Compared to Cabozantinib in Certain Previously Treated Patients With Advanced Renal Cell Carc
-
Cogent Biosciences Highlights Additional Data with Six Bezuclastinib Posters from SUMMIT Trial at 2026 AAAAI Annual Meeting
-
Blueprint Medicines, a Sanofi Company, Announces Four-Year PIONEER Data Showing Sustained Benefit and Long-Term Safety of AYVAKIT® (avapritinib) in Indolent Systemic Mastocytosis
-
9 Best Coin Picks Alert: Stage 9 APEMARS Presale Set for Jump for Altcoin Traders
-
Trail Life USA applauds Secretary Hegseth's recognition of its premier boy-focused program
-
BTC yearly returns outperformed by first ever onchain fund memecoin!

